Inclisiran – May 2023

• Brand names:
  • Leqvio®
• Pharmaceutical Company:
  • Novartis Pharmaceuticals Australia Pty Limited
• Condition/Indication: Hypercholesterolaemia
• Meeting Date: May 2023
• Public Summary Document (PSD) March 2023 May 2023 PBAC Meetings – (PDF 770KB)
• Public Summary Document (PSD) March 2023 May 2023 PBAC Meetings – (Word 151KB)

Related Public Summary Documents

Inclisiran – March 2023